StockData
Opthea Ltd logo

Opthea Ltd (CKDXF) stock

CKDXFOTCBiological Products, (No Diagnostic Substances)Fiscal year ends June 30Also trades as CYVNY
Financials through fiscal 2025, year ended Jun 30, 2025Last filing: 20-F on Sep 15, 2025Score 0/30
$0.01+0.00 (0.00%)

Close on Oct 19, 2026Market cap –P/E –Yield –

Opthea r&d expenses

Research and development expenses are spending on new products and technology.

For fiscal 2025 it was $126.83M, down 28.1% from the year before. The highest annual figure on record is $176.33M in fiscal 2024.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Jun 30, 2025$126.83M-28.1%
FY2024Jun 30, 2024$176.33M+36.9%
FY2023Jun 30, 2023$128.83M+58.2%
FY2022Jun 30, 2022$81.45M+214.6%
FY2021Jun 30, 2021$25.89M+114.6%
FY2020Jun 30, 2020$12.06M-46.2%
FY2019Jun 30, 2019$22.42M–

More Opthea figures

See a number that looks wrong?